Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Evidence and anecdotes: an analysis of human gene patenting controversies.

Caulfield T, Cook-Deegan RM, Kieff FS, Walsh JP.

Nat Biotechnol. 2006 Sep;24(9):1091-4. No abstract available.

2.

Patenting pieces of people.

[No authors listed]

Nat Biotechnol. 2003 Apr;21(4):341. No abstract available.

PMID:
12665804
3.

Patenting applied to genetic sequence information.

Duval M, Hsieh TF.

Biotechnol Genet Eng Rev. 2006;23:317-30. Review. No abstract available.

PMID:
22530515
4.

Shares in the human genome--the future of patenting DNA.

Thomas SM, Hopkins MM, Brady M.

Nat Biotechnol. 2002 Dec;20(12):1185-8. No abstract available.

PMID:
12454661
5.

DNA patenting: the end of an era?

Hopkins MM, Mahdi S, Patel P, Thomas SM.

Nat Biotechnol. 2007 Feb;25(2):185-7. Review.

PMID:
17287750
6.

Patenting the parts.

[No authors listed]

Nat Biotechnol. 2007 Aug;25(8):822. No abstract available.

PMID:
17687343
7.

Impact of gene patenting on R&D and commerce.

Stott M, Valentine J.

Nat Biotechnol. 2003 Jul;21(7):729-31; author reply 731. No abstract available.

PMID:
12833081
8.

From human genes to stem cells: new challenges for patent law?

Caulfield TA.

Trends Biotechnol. 2003 Mar;21(3):101-3.

PMID:
12628363
9.

Transparency tools in gene patenting for informing policy and practice.

Jefferson OA, Köllhofer D, Ehrich TH, Jefferson RA.

Nat Biotechnol. 2013 Dec;31(12):1086-93. doi: 10.1038/nbt.2755. No abstract available.

PMID:
24316644
10.

Biotechnology patents under fire.

Royzman I.

Nat Biotechnol. 2015 Sep;33(9):925-6. doi: 10.1038/nbt.3334. No abstract available.

PMID:
26348959
11.

A nail in the coffin for DNA sequence patents?

Yamanaka M.

Nat Biotechnol. 2008 Oct;26(10):1085-6. doi: 10.1038/nbt1008-1085. No abstract available.

PMID:
18846072
12.

Patentability of synthetic biology inventions in Europe.

Rutz B.

Biotechnol J. 2010 Jan;5(1):11-3. doi: 10.1002/biot.200900260. No abstract available.

PMID:
20069577
13.

Ownership at too high a price?

[No authors listed]

Nat Biotechnol. 2003 Sep;21(9):953. No abstract available.

PMID:
12949537
14.

Patent protection and access to genetic resources.

Shimbo I, Ito Y, Sumikura K.

Nat Biotechnol. 2008 Jun;26(6):645-7. doi: 10.1038/nbt0608-645. Review. No abstract available.

PMID:
18536683
15.

A Lockean argument against gene patenting.

Murray D.

Bus Prof Ethics J. 2001 Fall;20(3-4):129-43. No abstract available.

PMID:
15195649
16.

US court case to define EST patentability.

Lawrence S.

Nat Biotechnol. 2005 May;23(5):513. No abstract available.

PMID:
15877055
17.

Patenting pluripotence: the next battle for stem cell intellectual property.

Vrtovec KT, Scott CT.

Nat Biotechnol. 2008 Apr;26(4):393-5. doi: 10.1038/nbt0408-393. Review.

PMID:
18392018
18.

The human genome as common heritage: common sense or legal nonsense?

Ossorio PN.

J Law Med Ethics. 2007 Fall;35(3):425-39.

PMID:
17714252
19.

Biotechs sue Columbia over fourth Axel patent.

Howard K.

Nat Biotechnol. 2003 Sep;21(9):955-6. No abstract available.

PMID:
12949538
20.

Who owns the human genome? What can ownership mean with respect to genes?

Markl H.

IIC Int Rev Ind Prop Copyr Law. 2002;33(1):1-5. No abstract available.

PMID:
15156889

Supplemental Content

Support Center